Association of genetic variants at CETP, AGER, and CYP4F2 locus with the risk of atrophic age‐related macular degeneration. Issue 9 (14th July 2020)

• Record Type: Journal Article
• Authors: Liutkeviciene, Rasa; Vilkeviciute, Alvita; Kriauciuniene, Loresa; Banevicius, Mantas; Budiene, Brigita; Stanislovaitiene, Daiva; Zemaitiene, Reda; Deltuva, Vytenis P.
• Is Part Of: Molecular genetics & genomic medicine. Volume 8:Issue 9(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-07-14
• Subjects: age‐related macular degeneration -- CYP4F2 -- CETP -- AGER -- CYP4F2 -- gene polymorphism; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.1357
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: Age‐related macular degeneration (AMD) is the leading cause of blindness in the elderly individuals. The etiology of AMD includes environmental and genetic factors. Methods: We aimed to determine the association between CETP (rs5882; rs708272; rs3764261; rs1800775; rs2303790), AGER (rs1800624; rs1800625), and CYP4F2 (rs1558139) gene polymorphisms and development of atrophic AMD. About 52 patients with atrophic AMD and 800 healthy control subjects were evaluated. The genotyping of single‐nucleotide polymorphisms in CETP, AGER, and CYP4F2 was carried out using the real‐time‐PCR method. Results: Genetic risk models in the analysis of CETP rs5882 revealed statistically significant variables with increased risk of atrophic AMD in the codominant ( p < .001), dominant ( p < .001), recessive ( p < .001), and additive ( p < .001) models with the highest 25.4‐fold increased risk of atrophic AMD in the codominant model ( p < .001). The AGER rs1800625 was associated with a highly increased risk of atrophic AMD in the codominant ( p < .001), recessive ( p < .001), and additive ( p < .001) genetic models. Conclusion: We identified two polymorphisms with a higher risk of atrophic AMD ( CETP rs5882 and AGER rs1800625). Abstract : We aimed to determine the frequency of the genotypes of CETP(rs5882; rs708272; rs3764261; rs1800775; rs2303790), RAGE (rs1800624; rs1800625) and CYP4F2 (rs1558139) in patients (pts) with atrophic age‐related macular degeneration (AMD). We identified 2 polymorphisms with higher risk of atrophic AMD (rs5882 and rs1800625) and one protective polymorphism (rs3764261).